Granite Point Capital Management, L.P. - EVAXION BIOTECH A S ownership

EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 8 filers reported holding EVAXION BIOTECH A S in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of EVAXION BIOTECH A S
ValueSharesWeighting
Q2 2021$911,000
-31.2%
117,690
-47.6%
0.03%
-30.6%
Q1 2021$1,325,000224,6010.05%
Other shareholders
EVAXION BIOTECH A S shareholders Q3 2021
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 167,500$740,0000.95%
LUMINUS MANAGEMENT LLC 777,990$3,439,0000.81%
Kepos Capital LP 40,000$177,0000.02%
ETF MANAGERS GROUP, LLC 7,000$31,0000.00%
MORGAN STANLEY 3,696$16,0000.00%
Citadel Advisors 140,600$621,0000.00%
Citadel Advisors 13,900$61,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 25,600$114,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 30,180$134,0000.00%
SIMPLEX TRADING, LLC 400$1,0000.00%
View complete list of EVAXION BIOTECH A S shareholders